Autoimmune response to AGE modified human DNA: Implications in type 1 diabetes mellitus

Aims: Non-enzymatic glycation of DNA both in vivo and in vitro results in generation of free radicals, known as glycoxidation. Glycoxidation leads to structural perturbation of DNA resulting in generation of neo-antigenic epitopes having implication in autoimmune disorders like diabetes mellitus. In...

Full description

Bibliographic Details
Main Authors: Saheem Ahmad, Moin Uddin, Safia Habib, Uzma Shahab, Khursheed Alam, Asif Ali
Format: Article
Language:English
Published: Elsevier 2014-09-01
Series:Journal of Clinical & Translational Endocrinology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214623714000167
_version_ 1819169254273974272
author Saheem Ahmad
Moin Uddin
Safia Habib
Uzma Shahab
Khursheed Alam
Asif Ali
author_facet Saheem Ahmad
Moin Uddin
Safia Habib
Uzma Shahab
Khursheed Alam
Asif Ali
author_sort Saheem Ahmad
collection DOAJ
description Aims: Non-enzymatic glycation of DNA both in vivo and in vitro results in generation of free radicals, known as glycoxidation. Glycoxidation leads to structural perturbation of DNA resulting in generation of neo-antigenic epitopes having implication in autoimmune disorders like diabetes mellitus. In this study human placental DNA was glycated with methylglyoxal (MG) and lysine (Lys) in the presence of Cu2+ and its auto-antibody binding was probed in Type 1 diabetes patients. Methods: Glycation was carried out by incubating DNA with MG, Lys and Cu2+ for 24 h at 37 °C. Carboxyethyl deoxyguanosine (CEdG) formed in glycation reaction was studied by LC-MS and the pathway for Amadori formation was studied by ESI-MS techniques. Furthermore, binding characteristics of auto-antibodies in diabetes patients were assessed by direct binding, competitive ELISA and band shift assay. Results: DNA glycation with MG, Lys and Cu2+ results in the formation of CEdG (marker of DNA glycation) which was confirmed by LC-MS. The intermediate stages of glycation were confirmed by ESI-MS technique. Serum from diabetes patients exhibited enhanced binding and specificity for glycated DNA as compared to native form. Conclusions: Glycation of DNA has resulted in structural perturbation causing generation of neo-antigenic epitopes thus recognizing auto-antibodies in diabetes.
first_indexed 2024-12-22T19:16:34Z
format Article
id doaj.art-6e17560c53214f26a29f32881606a7f1
institution Directory Open Access Journal
issn 2214-6237
language English
last_indexed 2024-12-22T19:16:34Z
publishDate 2014-09-01
publisher Elsevier
record_format Article
series Journal of Clinical & Translational Endocrinology
spelling doaj.art-6e17560c53214f26a29f32881606a7f12022-12-21T18:15:30ZengElsevierJournal of Clinical & Translational Endocrinology2214-62372014-09-0113667210.1016/j.jcte.2014.05.002Autoimmune response to AGE modified human DNA: Implications in type 1 diabetes mellitusSaheem Ahmad0Moin Uddin1Safia Habib2Uzma Shahab3Khursheed Alam4Asif Ali5Department of Biochemistry, J.N. Medical College, Faculty of Medicine, Aligarh Muslim University, Aligarh, IndiaDepartment of Biochemistry, J.N. Medical College, Faculty of Medicine, Aligarh Muslim University, Aligarh, IndiaBiochemistry Section, Women's College, Aligarh Muslim University, Aligarh, IndiaDepartment of Biochemistry, J.N. Medical College, Faculty of Medicine, Aligarh Muslim University, Aligarh, IndiaDepartment of Biochemistry, J.N. Medical College, Faculty of Medicine, Aligarh Muslim University, Aligarh, IndiaDepartment of Biochemistry, J.N. Medical College, Faculty of Medicine, Aligarh Muslim University, Aligarh, IndiaAims: Non-enzymatic glycation of DNA both in vivo and in vitro results in generation of free radicals, known as glycoxidation. Glycoxidation leads to structural perturbation of DNA resulting in generation of neo-antigenic epitopes having implication in autoimmune disorders like diabetes mellitus. In this study human placental DNA was glycated with methylglyoxal (MG) and lysine (Lys) in the presence of Cu2+ and its auto-antibody binding was probed in Type 1 diabetes patients. Methods: Glycation was carried out by incubating DNA with MG, Lys and Cu2+ for 24 h at 37 °C. Carboxyethyl deoxyguanosine (CEdG) formed in glycation reaction was studied by LC-MS and the pathway for Amadori formation was studied by ESI-MS techniques. Furthermore, binding characteristics of auto-antibodies in diabetes patients were assessed by direct binding, competitive ELISA and band shift assay. Results: DNA glycation with MG, Lys and Cu2+ results in the formation of CEdG (marker of DNA glycation) which was confirmed by LC-MS. The intermediate stages of glycation were confirmed by ESI-MS technique. Serum from diabetes patients exhibited enhanced binding and specificity for glycated DNA as compared to native form. Conclusions: Glycation of DNA has resulted in structural perturbation causing generation of neo-antigenic epitopes thus recognizing auto-antibodies in diabetes.http://www.sciencedirect.com/science/article/pii/S2214623714000167DNAMethylGlyoxalGlycationAuto-antibodyDiabetes mellitus
spellingShingle Saheem Ahmad
Moin Uddin
Safia Habib
Uzma Shahab
Khursheed Alam
Asif Ali
Autoimmune response to AGE modified human DNA: Implications in type 1 diabetes mellitus
Journal of Clinical & Translational Endocrinology
DNA
MethylGlyoxal
Glycation
Auto-antibody
Diabetes mellitus
title Autoimmune response to AGE modified human DNA: Implications in type 1 diabetes mellitus
title_full Autoimmune response to AGE modified human DNA: Implications in type 1 diabetes mellitus
title_fullStr Autoimmune response to AGE modified human DNA: Implications in type 1 diabetes mellitus
title_full_unstemmed Autoimmune response to AGE modified human DNA: Implications in type 1 diabetes mellitus
title_short Autoimmune response to AGE modified human DNA: Implications in type 1 diabetes mellitus
title_sort autoimmune response to age modified human dna implications in type 1 diabetes mellitus
topic DNA
MethylGlyoxal
Glycation
Auto-antibody
Diabetes mellitus
url http://www.sciencedirect.com/science/article/pii/S2214623714000167
work_keys_str_mv AT saheemahmad autoimmuneresponsetoagemodifiedhumandnaimplicationsintype1diabetesmellitus
AT moinuddin autoimmuneresponsetoagemodifiedhumandnaimplicationsintype1diabetesmellitus
AT safiahabib autoimmuneresponsetoagemodifiedhumandnaimplicationsintype1diabetesmellitus
AT uzmashahab autoimmuneresponsetoagemodifiedhumandnaimplicationsintype1diabetesmellitus
AT khursheedalam autoimmuneresponsetoagemodifiedhumandnaimplicationsintype1diabetesmellitus
AT asifali autoimmuneresponsetoagemodifiedhumandnaimplicationsintype1diabetesmellitus